Deciphera Pharmaceuticals, LLC
USPTO PatentsView assignee record - 65 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Deciphera ranks #5,274 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 7 technology areas.
- #5,274
- of 49,997 US assignees by volume
- Top 11%
- by Innovation Score (51.9/100)
- 13.5
- avg claims per patent
- +300%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5274 · US Corporation #5,274 · 65 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 65 grants
- UPPER-Q #5,274/49,997
- PHOTO-FINISH Comfort Research
- CPC-NARROW A61P · 7 areas
- INNOV-PAR 51.9/100
- CLAIMS-RICH 13.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +300% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Comfort Research, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Deciphera’s 51.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Deciphera
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Deciphera Pharmaceut… · this assignee
Deciphera Pharmaceut… · this assignee
52 score
- IGT Global Soulutions · near
IGT Global Soulutions · near
52 score
- Qiagen · near
Qiagen · near
52 score
- Thunder Power New… · near
Thunder Power New… · near
52 score
- Touchtunes Music · near
Touchtunes Music · near
52 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Deciphera's Innovation Score is 51.9/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Deciphera?
Each dot is one of Deciphera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Deciphera’s own 13.5 claims/patent is ABOVE the 12.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Deciphera's grants concentrate
Deciphera Pharmaceuticals, LLC is a focused PatentsView assignee: 7 CPC subclasses with 86.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (17 grants) versus a trough of 4 in 2021. By volume, Deciphera sits between Comfort Research, LLC and Evapco, Inc..
Deciphera's three-year grant acceleration
Deciphera Pharmaceuticals, LLC shows 40 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Deciphera's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Comfort Research
Comfort Research, LLC
65 patents
- Cupp Computing AS
Cupp Computing AS
65 patents
- DRS Network & Ima…
DRS Network & Imaging Systems, LLC
65 patents
- Darex
Darex, LLC
65 patents
- Elite Semiconduct…
Elite Semiconductor Memory Technology Inc.
65 patents
- Energy Recovery
Energy Recovery, Inc.
65 patents
- Envision Aesc Jap…
Envision Aesc Japan Ltd.
65 patents
- Evapco
Evapco, Inc.
65 patents
- Deciphera Pharmac… ◀
Deciphera Pharmaceuticals, LLC
65 patents
What this shows Deciphera holds 65 patents at rank #5,275, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Deciphera
By rank, the assignees closest to #5,275 in granted patent volume.
- Comfort Research, LLC #5,271 · 65 patents
- Cupp Computing AS #5,272 · 65 patents
- DRS Network & Imaging Systems, LLC #5,273 · 65 patents
- Darex, LLC #5,274 · 65 patents
- Elite Semiconductor Memory Technology Inc. #5,276 · 65 patents
- Energy Recovery, Inc. #5,277 · 65 patents
- Envision Aesc Japan Ltd. #5,278 · 65 patents
- Evapco, Inc. #5,279 · 65 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Deciphera's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Deciphera, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Deciphera ranks #313 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (52 here).
Similar claim depth
Nearest assignees by average claims per patent (13.5 here).
Deciphera's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 9.2% |
| 2016 | 5 | 7.7% |
| 2021 | 4 | 6.2% |
| 2022 | 10 | 15.4% |
| 2023 | 13 | 20.0% |
| 2024 | 17 | 26.2% |
| 2025partial year | 10 | 15.4% |
Which technologies does Deciphera Pharmaceuticals, LLC patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Deciphera Pharmaceuticals, LLC's patent record in context - here's where to go next.
- Deciphera Pharmaceuticals, LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 86.2% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #5,274 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Deciphera Pharmaceuticals, LLC against Comfort Research, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 51.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.